rs3735887
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_024759.3(NIPAL2):c.1067+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,612,268 control chromosomes in the GnomAD database, including 220,036 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as (no stars).
Frequency
Consequence
NM_024759.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024759.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NIPAL2 | TSL:1 MANE Select | c.1040-294G>A | intron | N/A | ENSP00000407087.2 | Q9H841-2 | |||
| NIPAL2 | c.1001-294G>A | intron | N/A | ENSP00000522865.1 | |||||
| NIPAL2 | TSL:2 | c.1067+1G>A | splice_donor intron | N/A | ENSP00000339256.3 | Q9H841-1 |
Frequencies
GnomAD3 genomes AF: 0.529 AC: 80415AN: 151894Hom.: 21398 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.542 AC: 136366AN: 251370 AF XY: 0.542 show subpopulations
GnomAD4 exome AF: 0.520 AC: 758742AN: 1460256Hom.: 198617 Cov.: 41 AF XY: 0.521 AC XY: 378176AN XY: 726472 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.529 AC: 80485AN: 152012Hom.: 21419 Cov.: 32 AF XY: 0.533 AC XY: 39616AN XY: 74288 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.